DOH Prescription Drug Monitoring Program

The Rhode Island Department of Health is soliciting proposals for a single vendor to implement and operate a comprehensive, cloud-based Prescription Drug Monitoring Program (PDMP). The system is designed to collect, manage, and analyze data on controlled substance prescriptions for Schedules II through V and opioid antagonists to enhance patient safety and prevent drug misuse. Key technical requirements include a secure, mobile-responsive web portal that supports interstate data sharing and integration with Electronic Health Records and pharmacy dispensing systems. The solution should preferably be FedRAMP certified and must comply with CMS implementation standards, the Medicaid PARTNERSHIP Act, and specific Rhode Island General Laws. The contract features a base period from January 1, 2027, to April 30, 2028, with four optional extension years. Performance begins with a stakeholder engagement kickoff in January 2027, followed by user experience design, legal reviews, and a data integration pilot. Proposals are evaluated on a 100-point scale, with 70 points allocated to technical qualifications and presentations and 30 points to cost. Awardees must adhere to strict federal funding requirements, including 45 CFR Part 75, the Byrd Anti-Lobbying Amendment, and various non-discrimination laws. Additionally, the vendor must comply with rigorous cybersecurity policies, prohibiting offshore access to production systems and requiring a Business Associate Agreement for data privacy. Invoicing is conducted monthly based on actual expenditures, with payments submitted to the RIDOH Project Officer by the 10th of each month.